Cytomegalovirus Infection in Seronegative Patients Treated With Prophylaxis: Case-Controlled Study

Human Cytomegalovirus (HCMV) – Revised

“…As far as the transplantation of solid organs is concerned, a prophylaxis with antiviral substances is becoming more and more common [53][54][55]. However, preventive measures should always be based on the severity of the immunosuppression, the risk of reactivation of a latent HCMV infection, and the tolerability of the antiviral agent [6,7,51].…”